文献速递胸部CT

临床与胸部CT特征作为COVID-19临床进展的预测工具:一种新型半定量评分系统的提出

Clinical and chest CT features as a predictive tool for COVID-19 clinical progress: introducing a novel semi-quantitative scoring system.
PubMed 文献 · Eur Radiol · 2021-01-15

本研究基于2020年3月27日至4月26日转诊至三级大学医院呼吸分诊的739例临床高度疑似COVID-19且行胸部CT的患者,提出一种新型35分半定量评分系统评估肺部受累(PI),并比较不同结局组的人口学、临床及CT参数。多因素校正后预测ICU入院的截断值为年龄≥53岁、SpO2≤91%、PI评分≥8(死亡为15),三者联合预测ICU入院和死亡的准确率分别为81.9%和91.4%。作者强烈推荐将年龄≥53岁、SpO2≤91%、PI评分≥8或仅高PI评分者视为高风险患者以进一步管理和制定护理计划。

要点

  • 胸部CT是医院分诊中优先排序患者的有价值工具。
  • 设计了一种更准确的新型35分半定量评分系统以预测COVID-19患者结局。
  • 年龄≥53岁、SpO2≤91%、PI评分≥8或仅高PI评分者应被视为高风险患者。

核心结论

  • 作者强烈推荐将年龄≥53岁、SpO2≤91%、PI评分≥8或仅高PI评分者视为高风险患者,以进一步管理和制定护理计划。

研究设计与样本

  • 本研究为单中心研究,纳入2020年3月27日至4月26日转诊至三级大学医院呼吸分诊、临床高度疑似COVID-19且行胸部CT扫描的患者739例(平均年龄49.2±17.2岁,男性56.7%)。
  • 确诊COVID-19定义为rRT-PCR阳性,或临床高度可疑且胸部CT有典型肺部表现,共439例(59.6%)。
  • 根据结局将患者分为门诊、普通病房住院、ICU住院和死亡组,比较其人口学、临床及胸部CT参数。
  • 采用新型半定量评分系统对肺部CT特征进行评分以评估肺部受累(PI)。

关键影像表现/征象

  • 确诊COVID-19患者中最常见的胸部CT特征为磨玻璃影(GGO)(93.3%)、胸膜下外周分布(60.3%)、多肺叶受累(79.7%)、双侧受累(76.6%)及下叶(RLL和/或LLL)受累(89.1%)。
  • SpO2较低、年龄较大、呼吸频率较高、总PI评分或PI密度评分较高、弥漫分布或多肺叶、双侧或下叶受累的患者更可能入住ICU或死亡。

诊断标准与关键数值

  • 校正混杂因素后,预测ICU入院的截断值为年龄≥53岁、SpO2≤91%、PI评分≥8;预测死亡的PI评分截断值为15。
  • 三项因素联合预测ICU入院的特异度为89.1%、准确率为81.9%。
  • 三项因素联合预测死亡的特异度为95%、准确率为91.4%。
  • 单独评估高PI评分在预测结局方面也具有高敏感度、特异度和阴性预测值。

临床应用与阅片要点

  • 作者强烈推荐将年龄≥53岁、SpO2≤91%、PI评分≥8或仅高PI评分者视为高风险患者,以进一步管理和制定护理计划。
  • 胸部CT是医院分诊中优先排序患者的有价值工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Proposing a scoring tool to predict COVID-19 patients' outcomes based on initially assessed clinical and CT features.

METHODS: All patients, who were referred to a tertiary-university hospital respiratory triage (March 27-April 26, 2020), were highly clinically suggestive for COVID-19 and had undergone a chest CT scan were included. Those with positive rRT-PCR or highly clinically suspicious patients with typical chest CT scan pulmonary manifestations were considered confirmed COVID-19 for additional analyses. Patients, based on outcome, were categorized into outpatient, ordinary-ward admitted, intensive care unit (ICU) admitted, and deceased; their demographic, clinical, and chest CT scan parameters were compared. The pulmonary chest CT scan features were scaled with a novel semi-quantitative scoring system to assess pulmonary involvement (PI).

RESULTS: Chest CT scans of 739 patients (mean age = 49.2 ± 17.2 years old, 56.7% male) were reviewed; 491 (66.4%), 176 (23.8%), and 72 (9.7%) cases were managed outpatient, in an ordinary ward, and ICU, respectively. A total of 439 (59.6%) patients were confirmed COVID-19 cases; their most prevalent chest CT scan features were ground-glass opacity (GGO) (93.3%), pleural-based peripheral distribution (60.3%), and multi-lobar (79.7%), bilateral (76.6%), and lower lobes (RLL and/or LLL) (89.1%) involvement. Patients with lower SpO2, advanced age, RR, total PI score or PI density score, and diffuse distribution or involvement of multi-lobar, bilateral, or lower lobes were more likely to be ICU admitted/expired. After adjusting for confounders, predictive models found cutoffs of age ≥ 53, SpO2 ≤ 91, and PI score ≥ 8 (15) for ICU admission (death). A combination of all three factors showed 89.1% and 95% specificity and 81.9% and 91.4% accuracy for ICU admission and death outcomes, respectively. Solely evaluated high PI score had high sensitivity, specificity, and NPV in predicting the outcome as well.

CONCLUSION: We strongly recommend patients with age ≥ 53, SpO2 ≤ 91, and PI score ≥ 8 or even only high PI score to be considered as high-risk patients for further managements and care plans.

KEY POINTS: • Chest CT scan is a valuable tool in prioritizing the patients in hospital triage. • A more accurate and novel 35-scale semi-quantitative scoring system was designed to predict the COVID-19 patients' outcome. • Patients with age ≥ 53, SpO2 ≤ 91, and PI score ≥ 8 or even only high PI score should be considered high-risk patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Salahshour F, Mehrabinejad MM, Nassiri Toosi M, et al. Clinical and chest CT features as a predictive tool for COVID-19 clinical progress: introducing a novel semi-quantitative scoring system. Eur Radiol. 2021. PMID: 33449185. doi:10.1007/s00330-020-07623-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。